Drug intelligence / Profile preview

Estring (estradiol)

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Vaginal
01

Overview

Estring is a vaginal ring delivery system for estradiol, a naturally occurring human estrogen. It is indicated for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with menopause, such as vaginal dryness, burning, and dyspareunia. The ring is designed to release a low dose of estradiol (approximately 7.5 micrograms per 24 hours) consistently over a 90-day period. Estradiol works by binding to and activating estrogen receptors in the vaginal tissues, promoting the restoration of the vaginal epithelium, increasing secretions, and maintaining a healthy vaginal pH. This localized delivery minimizes systemic absorption compared to oral estrogen therapy, reducing the risk of systemic side effects while effectively managing local urogenital symptoms.

Brand names
Estring
Other names
17-beta-estradiolestradiol vaginal ring
02

Targets

ESR1 (ERα)ESR2 (ERβ)GPER1 (G protein-coupled estrogen receptor 1)

Beyond the preview

Go deeper on Estring (estradiol).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Estring (estradiol).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call